Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

Grande E, Sibai M, Grases D, Andrada E, Reig O, Escobosa M, Azueta A, Castellano D, Puente J, Martínez de Villarreal J, Font A, Alonso-Gordoa T, Benítez R, Moreno-Oya A, Álvarez-Maestro M, Burgos J, Climent MA, Domínguez M, Galván P, Galante I, García JF, Perez E, García Del Muro X, Guerrero-Ramos F, Marqués M, Maroto P, Paramio JM, Pinto A, Prat A, Malats N, Durán I, Porta-Pardo E, Real FX

Open source

DOI: 10.1016/j.xcrm.2026.102878
Published: 2026 Jul 21
Container: Cell reports. Medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2026.102878,
  title = {Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.},
  author = {Grande E and Sibai M and Grases D and Andrada E and Reig O and Escobosa M and Azueta A and Castellano D and Puente J and Martínez de Villarreal J and Font A and Alonso-Gordoa T and Benítez R and Moreno-Oya A and Álvarez-Maestro M and Burgos J and Climent MA and Domínguez M and Galván P and Galante I and García JF and Perez E and García Del Muro X and Guerrero-Ramos F and Marqués M and Maroto P and Paramio JM and Pinto A and Prat A and Malats N and Durán I and Porta-Pardo E and Real FX},
  year = {2026},
  journal = {Cell reports. Medicine},
  doi = {10.1016/j.xcrm.2026.102878},
  url = {https://doi.org/10.1016/j.xcrm.2026.102878}
}

RIS

TY  - JOUR
TI  - Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.
AU  - Grande E
AU  - Sibai M
AU  - Grases D
AU  - Andrada E
AU  - Reig O
AU  - Escobosa M
AU  - Azueta A
AU  - Castellano D
AU  - Puente J
AU  - Martínez de Villarreal J
AU  - Font A
AU  - Alonso-Gordoa T
AU  - Benítez R
AU  - Moreno-Oya A
AU  - Álvarez-Maestro M
AU  - Burgos J
AU  - Climent MA
AU  - Domínguez M
AU  - Galván P
AU  - Galante I
AU  - García JF
AU  - Perez E
AU  - García Del Muro X
AU  - Guerrero-Ramos F
AU  - Marqués M
AU  - Maroto P
AU  - Paramio JM
AU  - Pinto A
AU  - Prat A
AU  - Malats N
AU  - Durán I
AU  - Porta-Pardo E
AU  - Real FX
PY  - 2026
JO  - Cell reports. Medicine
DO  - 10.1016/j.xcrm.2026.102878
UR  - https://doi.org/10.1016/j.xcrm.2026.102878
ER  -

APA

E, G., M, S., D, G., E, A., O, R., M, E., A, A., D, C., J, P., J, M. D. V., A, F., T, A., R, B., A, M., M, Á., J, B., MA, C., M, D., P, G., I, G., JF, G., E, P., X, G. D. M., F, G., M, M., P, M., JM, P., A, P., A, P., N, M., I, D., E, P., & FX, R. (2026). Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2026.102878

Source records

pubmed · retrieved 2026-09-26T13:53:45.342Z
europe-pmc · retrieved 2026-09-26T13:53:45.340Z